Who
Yuval Cohen
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Corbus Pharmaceuticals Holdings.
In numbers
- Trades disclosed
- 84
- Buys
- 26
- Sells
- 8
- Bought
- $159K
- Sold
- $4.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Dec 2014
- Last trade
- 7 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Aug 2026filed 10 Aug 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $171K17,000 at $10.08 | filing |
| 7 Aug 2026filed 10 Aug 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $171K17,000 at $10.08 | filing |
| 13 Feb 2026filed 18 Feb 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $108K13,871 at $7.78 | filing |
| 13 Feb 2026filed 18 Feb 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $108K13,871 at $7.78 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 27 Oct 2025filed 27 Oct 2025 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,973 at $0.00 | filing |
| 27 Oct 2025filed 27 Oct 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code M | $38K8,973 at $4.26 | filing |
| 27 Oct 2025filed 27 Oct 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $154K8,973 at $17.14 | filing |
| 24 Oct 2025filed 27 Oct 2025 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,660 at $0.00 | filing |
| 24 Oct 2025filed 27 Oct 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code M | $79K18,660 at $4.26 | filing |
| 24 Oct 2025filed 27 Oct 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $317K18,660 at $17.01 | filing |
| 14 Feb 2025filed 18 Feb 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $62K7,134 at $8.76 | filing |
| 31 Jan 2025filed 4 Feb 2025 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —228,800 at $0.00 | filing |
| 31 Jan 2025filed 4 Feb 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —68,100 at $0.00 | filing |
| 18 Jun 2024filed 18 Jun 2024 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,667 at $0.00 | filing |
| 18 Jun 2024filed 18 Jun 2024 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,770 at $0.00 | filing |
| 18 Jun 2024filed 18 Jun 2024 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,322 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.